A Population-Based Nested Case-Control Study in Taiwan: Use of 5α-Reductase Inhibitors Did Not Decrease Prostate Cancer Risk in Patients with Benign Prostate Hyperplasia

BACKGROUND. 5α-Reductase inhibitors (5ARIs) are commonly used to treat benign prostate hyperplasia (BPH) by blocking the conversion of testosterone into the more potent dihydrotestosterone. This study explored a possible association between the use of the 5ARIs finasteride and dutasteride and the su...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Liang, Ji-An, Sun, Li-Min, Lin, Ming-Chia, Chang, Shih-Ni, Sung, Fung-Chang, Muo, Chih-Hsin, Kao, Chia-Hung
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2012
Soggetti:
Outcomes Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399656/
https://ncbi.nlm.nih.gov/pubmed/22723508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0464
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi